Skip to content

KRAIG BIOCRAFT LABORATORIES, INC.: 10-K filed 2014-04-15

What KRAIG BIOCRAFT LABORATORIES, INC. reported in its annual report filed 2014-04-15 (fiscal FY 2013): 27 published measures, 83 facts as tagged in accession 0001354488-14-001882.

This filing

Form
10-K (annual report)
Filed
2014-04-15
Fiscal period
fiscal FY 2013
Accession
0001354488-14-001882 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KRAIG BIOCRAFT LABORATORIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-31311,217USD
At 2012-12-3178,752USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-311,512,619USD
At 2012-12-311,213,168USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-1,201,402USD
At 2012-12-31-1,134,416USD
At 2011-12-31-906,495USD
At 2010-12-31-619,185USD
At 2009-12-31-3,174,777USD
At 2008-12-31-1,899,353USD
At 2007-12-31-182,197USD
At 2006-12-31-257,706USD
At 2006-04-240USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-31295,381USD
At 2012-12-3153,782USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-7,467,685USD365
2006-04-25 to 2013-12-31-16,305,358USD2808
2012-01-01 to 2012-12-31-1,602,921USD366
2011-01-01 to 2011-12-31-1,295,310USD365
2010-01-01 to 2010-12-31-1,782,888USD365
2009-01-01 to 2009-12-31-1,432,091USD365
2008-01-01 to 2008-12-31-1,721,156USD366
2007-01-01 to 2007-12-31-472,986USD365
2006-04-25 to 2006-12-31-530,321USD251

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-800,154USD365
2006-04-25 to 2013-12-31-2,764,547USD2808
2012-01-01 to 2012-12-31-562,922USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,473USD365
2006-04-25 to 2013-12-3131,387USD2808
2012-01-01 to 2012-12-310USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,045,226USD365
2006-04-25 to 2013-12-313,097,507USD2808
2012-01-01 to 2012-12-31421,487USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-3,473USD365
2006-04-25 to 2013-12-31-37,579USD2808
2012-01-01 to 2012-12-31-192USD366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2006-04-25 to 2013-12-310USD2808
2012-01-01 to 2012-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-3114,093USD
At 2012-12-3116,508USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2006-04-25 to 2013-12-311,458,180USD2808
2012-01-01 to 2012-12-31550,000USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-2,280,469USD365
2006-04-25 to 2013-12-31-8,307,602USD2808
2012-01-01 to 2012-12-31-1,560,406USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-31297,124USD
At 2012-12-3162,244USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2006-04-25 to 2013-12-31147,913USD2808
2012-01-01 to 2012-12-3145,707USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-311,512,619USD
At 2012-12-311,203,790USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,280,469USD365
2006-04-25 to 2013-12-318,307,602USD2808
2012-01-01 to 2012-12-311,560,406USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-31489,434USD365
2006-04-25 to 2013-12-311,791,443USD2808
2012-01-01 to 2012-12-31465,293USD366

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-312,053,236USD
At 2012-12-311,320,337USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-3117,295USD
At 2012-12-3111,406USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-311,081,482USD
At 2012-12-31886,449USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-12-310USD
At 2012-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,375,528USD365
2006-04-25 to 2013-12-313,315,030USD2808
2012-01-01 to 2012-12-31379,326USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-315,888USD365
2006-04-25 to 2013-12-3117,294USD2808
2012-01-01 to 2012-12-315,583USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-5,187,216USD365
2006-04-25 to 2013-12-31-7,997,756USD2808
2012-01-01 to 2012-12-31-42,515USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,050,000USD365
2006-04-25 to 2013-12-312,973,527USD2808
2012-01-01 to 2012-12-31425,000USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31117,251USD365
2006-04-25 to 2013-12-31446,477USD2808
2012-01-01 to 2012-12-31-148,691USD366

Inspect the source

Entity
KRAIG BIOCRAFT LABORATORIES, INC. / CIK 0001413119
Captured
2026-09-20T08:02:08.774Z
SEC response SHA-256
920795b2181369f3ae04be68b2de22ae3d9ee7808a72922b976f9dc124464bc6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001413119.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))